Compare Garmin Ltd. (GRMN) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Garmin Ltd. vs Intuitive Surgical, Inc. — how do they compare? Garmin Ltd. trades at $247.76 (market cap $46.62B), while Intuitive Surgical, Inc. trades at $400.15 (market cap $137.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 3× Garmin Ltd.'s market cap, and Garmin Ltd. pays a 1.74% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.
| GRMN | ISRG | |
|---|---|---|
Market Cap | $46.62B | $137.76B |
Sector | Technology | Health |
52-Week High | $267.52 | $592.85 |
52-Week Low | $187.10 | $379.50 |
Enterprise Value | $44.09B | $133.24B |
Dividend Yield | 1.74% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Garmin (GRMN) trades at $241.39, down 0.91% on the day, with a bullish technical signal supported by moving averages and a neutral RSI near 52. The stock shows strong fundamentals with 2025 revenue of $7.25B, net income margin of 23.26%, and consistent earnings beats in recent quarters. Recent product launches in aviation and marine electronics highlight innovation, while cash flow remains positive at $199.21M in 2025.
GRMN presents a solid investment case with robust profitability and growth, though valuation ratios like a P/E of 26.98 suggest premium pricing. Risks include competitive pressures and market volatility, but analyst consensus targets $281.50, indicating ~17% upside. The outlook is positive if earnings momentum continues, supported by dividend stability and institutional confidence.
Intuitive Surgical (ISRG) trades at $379.50, down 6.78% amid broader market pressure, yet maintains strong fundamentals with 28.15% net margins and consistent earnings beats. The stock faces technical headwinds with bearish moving averages but shows oversold RSI conditions. Recent news highlights competitive pressures but also strong da Vinci 5 adoption and upcoming Q2 earnings on July 16, where analysts expect another beat. Revenue growth remains robust at $10.06B for 2025, up from $8.4B in 2024.
Despite near-term volatility, ISRG's leadership in robotic surgery and analyst consensus price target of $552.36 suggest significant upside. Key risks include intensifying global competition and margin pressures, but the company's innovation pipeline and expanding procedure volumes support long-term growth. Institutional sentiment remains positive with 69.6% buy ratings, positioning ISRG as a compelling recovery candidate post-earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Garmin Ltd.
Garmin produces GPS-enabled hardware and software for five verticals: fitness, outdoors, auto, aviation, and marine. The company relies on licensing mapping data to enable its hardware specialized for often niche activities like scuba diving or sailing. Garmin operates in 100 countries and sells its products via distributors as well as relationships with original equipment manufacturers.
Read more on GRMN →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
